Providing leading edge diagnostic solutions in oncology

AccuGenomics provides gene expression tests that accurately diagnose, monitor and inform cancer treatment. AccuGenomics' technologies generate the most comprehensive test results which ensure confidence in clinical decisions and provide credible and reliable gene expression data to the medical community.

Breaking News:

AccuGenomics Provides an AccuKit to Qura Therapeutics as Part of a Research Collaboration Agreement

AccuKit-HIV utilizes AccuGenomics’ Standardized Nucleic Acid Quantification (SNAQ) technology and standardized molecular testing kit WILMINGTON, NC, August 15, 2017 – AccuGenomics, Inc., a diagnostic company based in Wilmington, NC, today announced that the company has provided an AccuKit to the HIV Cure Center at the University of North Carolina at Chapel Hill and to Qura…

AccuGenomics Announces New Additions to Scientific Advisory Board

  AccuGenomics, Inc. Press Contact: Nick Lazaridis, Ph.D. Phone: 910.200.3228 Email: nlazaridis@accugenomics.com   AccuGenomics Announces New Additions to Scientific Advisory Board     – Preeminent experts in molecular diagnostics will provide guidance on the ongoing development of standardizing companion diagnostic technologies –   Wilmington, NC, June 8, 2017 – AccuGenomics, Inc., a diagnostic company based…

Oxford Global Seminar on NGS Quality Control Solutions

Dr. James Willey, co-founder and consultant to AccuGenomics, is presenting an Oxford Global seminar October 4th, 2016.  The talks title is “Quality Control Solutions to Facilitate Implementation of NGS in Cancer Diagnostics.”  The talk will expand upon his recent publications on the use of competitive template mixtures to provide quality metrics for RNASeq and DNASeq…

AccuGenomics will give a presentation at the SEQC-2 Workshop September 13-14, 2016, Bethesda, MD

Dr. Willey, AccuGenomics Co-Founder and consultant, has been asked to speak at the SEQC-2 workshop with the presentation title of “Quality‐control solutions for targeted NGS in Cancer Diagnostics.”  “Dr. Willey’s recent publications on standardizing the NGS RNAseq abundance measurements, and DNAseq quality assurance metrics provide needed quality controls for the application of NGS in the…